Search research articles
Contact Us
Filters
Showing results (21-30 of 186) with videos related to
Page
of 19
Sort By:
Cells
|
June 19, 2024
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
Matthew Tolerico, Sandra Merscher, Alessia Fornoni
Glomerular Diseases
|
February 8, 2023
Lupus Membranous Nephropathy
Claudio Ponticelli, Gabriella Moroni, Alessia Fornoni
Pharmaceutics
|
May 27, 2023
Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
Rachel Njeim, Sahar Alkhansa, Alessia Fornoni
Journal of Personalized Medicine
|
August 27, 2021
Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
Mengyuan Ge, Sandra Merscher, Alessia Fornoni
Nature Reviews. Nephrology
|
July 27, 2023
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
Drugs
|
November 22, 2005
Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis
Oliver Lenz, Alessia Fornoni, Gabriel Contreras
American Journal of Physiology. Renal Physiology
|
April 11, 2024
Mechanisms and implications of podocyte autophagy in chronic kidney disease
Rachel Njeim, Sandra Merscher, Alessia Fornoni
International Journal of Molecular Sciences
|
April 23, 2022
Implications of Sphingolipid Metabolites in Kidney Diseases
Shamroop Kumar Mallela, Sandra Merscher, Alessia Fornoni
Current Diabetes Reports
|
November 23, 2019
Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease
G Michelle Ducasa, Alla Mitrofanova, Alessia Fornoni
American Journal of Physiology. Renal Physiology
|
December 25, 2015
Systemic and renal lipids in kidney disease development and progression
Patricia Wahl, Gloria Michelle Ducasa, Alessia Fornoni
Page
of 19
Search research articles
Search
Showing results (21-30 of 186) with videos related to
Sort By:
Page
of 19
Cells
|
June 19, 2024
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
Matthew Tolerico, Sandra Merscher, Alessia Fornoni
Glomerular Diseases
|
February 8, 2023
Lupus Membranous Nephropathy
Claudio Ponticelli, Gabriella Moroni, Alessia Fornoni
Pharmaceutics
|
May 27, 2023
Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
Rachel Njeim, Sahar Alkhansa, Alessia Fornoni
Journal of Personalized Medicine
|
August 27, 2021
Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
Mengyuan Ge, Sandra Merscher, Alessia Fornoni
Nature Reviews. Nephrology
|
July 27, 2023
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
Drugs
|
November 22, 2005
Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis
Oliver Lenz, Alessia Fornoni, Gabriel Contreras
American Journal of Physiology. Renal Physiology
|
April 11, 2024
Mechanisms and implications of podocyte autophagy in chronic kidney disease
Rachel Njeim, Sandra Merscher, Alessia Fornoni
International Journal of Molecular Sciences
|
April 23, 2022
Implications of Sphingolipid Metabolites in Kidney Diseases
Shamroop Kumar Mallela, Sandra Merscher, Alessia Fornoni
Current Diabetes Reports
|
November 23, 2019
Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease
G Michelle Ducasa, Alla Mitrofanova, Alessia Fornoni
American Journal of Physiology. Renal Physiology
|
December 25, 2015
Systemic and renal lipids in kidney disease development and progression
Patricia Wahl, Gloria Michelle Ducasa, Alessia Fornoni
Page
of 19